drug
(sofosbuvir + velpatasvir + voxilaprevir)
Marketedupdated 3mo agoby $GILD GILEAD SCIENCES, INC.
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Mar 21, 2028
~1.6 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (32)
- Dec 1, 2037patentUS 11338007*PED
- Jun 1, 2037formulationUS 10912814
- Jun 1, 2037formulationUS 11338007
- Jul 30, 2034patentUS 11116783*PED
- Jul 17, 2034compositionUS 9296782
- Jan 30, 2034formulationUS 11116783
- May 16, 2033patentUS 8575135*PED
- May 16, 2033patentUS 8921341*PED
- May 16, 2033patentUS 8940718*PED
- Nov 16, 2032compositionUS 8575135
- Nov 16, 2032compositionUS 8921341
- Nov 16, 2032compositionUS 8940718
- Nov 16, 2032compositionUS 9868745
- Jun 11, 2031patentUS 8618076*PED4.8y
- Mar 13, 2031patentUS 9284342*PED4.6y
- Dec 11, 2030compositionUS 86180764.3y
- Sep 13, 2030compositionUS 92843424.1y
- Sep 26, 2029patentUS 7964580*PED3.1y
- Sep 26, 2029patentUS 8633309*PED3.1y
- Sep 26, 2029patentUS 8889159*PED3.1y
- Mar 26, 2029compositionUS 79645802.6y
- Mar 26, 2029compositionUS 86333092.6y
- Mar 26, 2029compositionUS 88891592.6y
- Sep 21, 2028patentUS 8334270*PED2.1y
- Sep 21, 2028patentUS 8580765*PED2.1y
- Sep 21, 2028patentUS 8735372*PED2.1y
- Sep 21, 2028patentUS 9085573*PED2.1y
- Mar 21, 2028compositionUS 83342701.6y
- Mar 21, 2028compositionUS 85807651.6y
- Mar 21, 2028compositionUS 87353721.6y
- Mar 21, 2028method-of-use (U-2039)US 89570461.6y
- Mar 21, 2028compositionUS 90855731.6y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 49m ago
Found something off?
comments(0)
5-min edit window · permanent after that